CRYOPORT INC (CYRX)
US2290503075 - Common Stock
Cryoport Expands IntegriCell™ Cryopreservation Services Solution with Opening of New Center of Excellence in Europe
/PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in supply chain solutions for the life sciences industry, today...
Cryoport Reports Third Quarter 2024 Financial Results
/PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) (Cryoport), a global leader in supply chain solutions for the life sciences industry, today announced financial...
Cryoport to Report Third Quarter 2024 Financial Results on November 7, 2024
/PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in supply chain solutions for the life sciences industry, today...
Cryoport and Gulf Coast Regional Blood Center Launch Strategic Alliance to Enhance Cellular Therapy Services
/PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in supply chain solutions for the life sciences industry, and Gulf Coast Regional...
TMRW Life Sciences and Cryoport Systems Form Strategic Partnership to Elevate Standards for Frozen Egg, Embryo, and Sperm Offsite Storage and Biologistics
/PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in supply chain solutions for the life sciences industry, and TMRW Life Sciences...
RSI Alert: CryoPort (CYRX) Now Oversold
Cryoport Launches its IntegriCell™ Cryopreservation Solution with Opening of New Facility at its Houston Campus
/PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or "the Company"), a global leader in supply chain solutions for the life sciences, today announced...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning!
Cryoport Reports Second Quarter 2024 Financial Results
Revenue improved sequentially across all businesses Commercial Cell & Gene Therapy revenue increased 51% year-over-year and 20% sequentially A record total of...
Cryoport Announces $200 Million Repurchase Program and the Repurchase of $160 Million of Convertible Senior Notes
/PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in supply chain solutions for the life sciences, today announced...
Cryoport to Report Second Quarter 2024 Financial Results on August 6, 2024
/PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in supply chain solutions for the life sciences, today announced...
Thursday Sector Leaders: General Contractors & Builders, Biotechnology Stocks
Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies
/PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in supply chain solutions for the life sciences, and Minaris Regenerative Medicine...
CryoPort is Now Oversold (CYRX)
Notable Tuesday Option Activity: CYRX, VUZI, HIMS
CryoPort Becomes Oversold (CYRX)
CryoPort Breaks Below 200-Day Moving Average - Notable for CYRX
CYRX Stock Earnings: CryoPort Misses EPS, Misses Revenue for Q1 2024
CYRX stock results show that CryoPort missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
CYRX Stock Earnings: CryoPort Misses EPS, Misses Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips CryoPort (NASDAQ:CYRX) just reported results for the first quarter of 2024.Cryo...
Cryoport Reports First Quarter 2024 Financial Results
/PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) (Cryoport), a global leader in supply chain solutions for the life sciences, today announced financial results...
Cryoport to Report First Quarter 2024 Financial Results on May 7, 2024
/PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX), a global leader in supply chain solutions for cell & gene therapies, today announced that the Company will...
Commit To Buy CryoPort At $10, Earn 11% Annualized Using Options
CYRX Crosses Below Key Moving Average Level
Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results
/PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in supply chain solutions for cell & gene therapies, today announced financial...